Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, today announced the appointment of Christopher W. Bodine to its Board of Directors, effective immediately. The addition of Mr. Bodine expands Watson's Board to ten members, of whom nine are independent. Mr. Bodine's career spans 36 years with two of the nation's leading (Fortune 200) retail and healthcare companies and brings to Watson a significant chain drug industry background.
Best Bar None Rallies Industry Support Against Mandatory Code For Alcohol Retailers
At this week's board meeting of responsible alcohol retailing scheme Best Bar None, Chairman Lord Rupert Redesdale shared his intention to table an amendment to the mandatory code of practice element of the Policing and Crime Bill. This he did on Wednesday 17th June.
Watson to Acquire Arrow Group
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has entered into a definitive agreement to acquire privately held Arrow Group for $1.75 billion in cash and stock. The combination of Watson and Arrow will result in a global pharmaceutical company with over $3 billion in revenue, commercial operations in over 20 countries, and a robust product portfolio and pipeline. Watson expects the transaction to close in the second half of 2009, and be accretive to cash earnings per share in 2010 before synergies.
CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence
MetroHealth Wall of Hope and Chris Evert Children's Hospital websites earn top honors
Musician's Friend Expands Selection of Pro Audio Equipment and Welcomes Audio Professionals
A Designs, Chandler LTD, Solid State Logic, True Systems, Focusrite, Daking USA, DW Fearn, Empirical Labs, GML, Royer, Rupert Neve Designs, TL Audio, Telefunken, and Tube Tech are among the high-performance brands offered at Musician's Friend
Related Searches
